The natural product derived Istodax was approved for cutaneous T-cell lymphoma by the US FDA, November 5, 2009.
Resources
- About the ASP
- Calendar of Events
- Grants and Awards
- Journal of Natural Products
- Member Directory
- Natural Products News
- Newsletter
- Outreach Activities
- Pharmacognosy and Natural Products Journals
- Pharmacognosy Employment
- Pharmacognosy Graduate Programs
- Pharmacognosy Links
- Pharmacognosy Photo Album
- Workshops
News & Announcements Archive
Follow us
